Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

NCT05008835 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

61

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated for business reasons.

Conditions

Osteoarthritis Pain

Interventions

DRUG: ACP-044 Dose A
DRUG: ACP-044 Dose B
DRUG: Placebo

Sponsor

ACADIA Pharmaceuticals Inc.